SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-013085
Filing Date
2022-05-19
Accepted
2022-05-19 17:04:29
Documents
1
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 17912
  Complete submission text file 0001437749-22-013085.txt   19425
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 BETHESDA METRO CENTER STE 700 C/O REGENERX BIOPHARMACEUTICALS INC BETHESDA MD 20814
Business Address
MCNAY JOSEPH C (Reporting) CIK: 0001257674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 22944006